864 related articles for article (PubMed ID: 10223488)
1. Diagnostic value of percent free prostate-specific antigen: retrospective analysis of a population-based screening study with emphasis on men with PSA levels less than 3.0 ng/mL.
Törnblom M; Norming U; Adolfsson J; Becker C; Abrahamsson PA; Lilja H; Gustafsson O
Urology; 1999 May; 53(5):945-50. PubMed ID: 10223488
[TBL] [Abstract][Full Text] [Related]
2. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination.
Uzzo RG; Pinover WH; Horwitz EM; Parlanti A; Mazzoni S; Raysor S; Mirchandani I; Greenberg RE; Pollack A; Hanks GE; Watkins-Bruner D
Urology; 2003 Apr; 61(4):754-9. PubMed ID: 12670560
[TBL] [Abstract][Full Text] [Related]
3. The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):779-84. PubMed ID: 7502415
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer.
Candas B; Cusan L; Gomez JL; Diamond P; Suburu RE; Lévesque J; Brousseau G; Bélanger A; Labrie F
Prostate; 2000 Sep; 45(1):19-35. PubMed ID: 10960839
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less.
Yamamoto T; Ito K; Ohi M; Kubota Y; Suzuki K; Fukabori Y; Kurokawa K; Yamanaka H
Urology; 2001 Dec; 58(6):994-8. PubMed ID: 11744475
[TBL] [Abstract][Full Text] [Related]
6. The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.
Bangma CH; Kranse R; Blijenberg BG; Schröder FH
Urology; 1995 Dec; 46(6):773-8. PubMed ID: 7502414
[TBL] [Abstract][Full Text] [Related]
7. Percent free PSA as an additional measure in a prostate cancer screen.
Miele ME
Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
[TBL] [Abstract][Full Text] [Related]
8. Relative contribution of digital rectal examination and transrectal ultrasonography in interpreting serum prostate-specific antigen values for screening prostate cancer in Arab men.
Sheikh M; Sinan T; Kehinde EO; Hussein AY; Anim JT; Al-Hunayan AA
Ann Saudi Med; 2007; 27(2):73-8. PubMed ID: 17356323
[TBL] [Abstract][Full Text] [Related]
9. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.
Schröder FH; van der Maas P; Beemsterboer P; Kruger AB; Hoedemaeker R; Rietbergen J; Kranse R
J Natl Cancer Inst; 1998 Dec; 90(23):1817-23. PubMed ID: 9839522
[TBL] [Abstract][Full Text] [Related]
11. Early detection of prostate cancer in the ESRD population.
Khairullah QT; Pamatmat SD; Chatha M; Provenzano R; Telang D; Temple M
Clin Nephrol; 2004 May; 61(5):308-15. PubMed ID: 15182125
[TBL] [Abstract][Full Text] [Related]
12. Population-based screening for prostate cancer by measuring total serum prostate-specific antigen in Iran.
Hosseini SY; Moharramzadeh M; Ghadian AR; Hooshyar H; Lashay AR; Safarinejad MR
Int J Urol; 2007 May; 14(5):406-11. PubMed ID: 17511722
[TBL] [Abstract][Full Text] [Related]
13. Utility of free/total prostate specific antigen (f/t PSA) ratio in diagnosis of prostate carcinoma.
Thakur V; Singh PP; Talwar M; Mukherjee U
Dis Markers; 2003-2004; 19(6):287-92. PubMed ID: 15258330
[TBL] [Abstract][Full Text] [Related]
14. Stratification of prostate-specific antigen level and results of transrectal ultrasonography and digital rectal examination as predictors of positive prostate biopsy.
Clark TW; Goldenberg L; Cooperberg PL; Wong AD; Singer J
Can Assoc Radiol J; 1997 Aug; 48(4):252-8. PubMed ID: 9282157
[TBL] [Abstract][Full Text] [Related]
15. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
16. Does free to total ratio of prostate-specific antigen alter decision-making on prostatic biopsy?
Alivizatos G; Deliveliotis C; Mitropoulos D; Raptides G; Louras G; Karayiannis A; Becopoulos T; Dimopoulos AM
Urology; 1996 Dec; 48(6A Suppl):71-5. PubMed ID: 8973704
[TBL] [Abstract][Full Text] [Related]
17. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
18. Clinical usefulness of free PSA in early detection of prostate cancer.
Luboldt HJ; Swoboda A; Börgermann C; Fornara P; Rübben H;
Onkologie; 2001 Feb; 24(1):33-7. PubMed ID: 11441278
[TBL] [Abstract][Full Text] [Related]
19. Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges.
Meshref AW; Bazinet M; Trudel C; Aronson S; Peloquin F; Nachabe M; Dessureault J; Aprikian AG; Begin LR; Elhilali MM
Urology; 1995 Jun; 45(6):972-9. PubMed ID: 7539562
[TBL] [Abstract][Full Text] [Related]
20. [Examination for indication of systematic biopsy for diagnosis of prostate cancer].
Muraoka K; Takahashi C; Yamamoto Y; Watanabe T; Hirakawa S; Miyagawa I
Nihon Hinyokika Gakkai Zasshi; 1999 Jul; 90(7):657-62. PubMed ID: 10481471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
